Ashland/$ASH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ashland
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
Ticker
$ASH
Sector
Primary listing
NYSE
Industry
Chemicals
Headquarters
Employees
3,200
ISIN
US0441861046
Website
Ashland Metrics
BasicAdvanced
$2.3B
-
-$2.43
0.57
$1.63
3.27%
Price and volume
Market cap
$2.3B
Beta
0.57
52-week high
$98.44
52-week low
$45.21
Average daily volume
549K
Dividend rate
$1.63
Financial strength
Current ratio
2.322
Quick ratio
0.819
Long term debt to equity
55.412
Total debt to equity
58.109
Interest coverage (TTM)
1.98%
Profitability
EBITDA (TTM)
408
Gross margin (TTM)
35.09%
Net profit margin (TTM)
-5.80%
Operating margin (TTM)
10.47%
Effective tax rate (TTM)
60.00%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
2.28%
Return on equity (TTM)
-3.02%
Valuation
Price to revenue (TTM)
1.236
Price to book
0.93
Price to tangible book (TTM)
3.72
Price to free cash flow (TTM)
72.209
Free cash flow yield (TTM)
1.38%
Free cash flow per share (TTM)
70.21%
Dividend yield (TTM)
3.21%
Forward dividend yield
3.27%
Growth
Revenue change (TTM)
-7.67%
Earnings per share change (TTM)
-164.90%
3-year revenue growth (CAGR)
-4.66%
10-year revenue growth (CAGR)
-10.46%
3-year earnings per share growth (CAGR)
-46.71%
10-year earnings per share growth (CAGR)
-8.31%
3-year dividend per share growth (CAGR)
10.52%
10-year dividend per share growth (CAGR)
1.76%
What the Analysts think about Ashland
Analyst ratings (Buy, Hold, Sell) for Ashland stock.
Bulls say / Bears say
Ashland's strategic divestiture of its nutraceuticals business to Turnspire Capital Partners allows the company to focus on core operations and strategic growth initiatives, potentially enhancing profitability. (csimarket.com)
The expansion of Ashland's pharmaceutical manufacturing plant in Brazil, with a $10 million investment, aims to meet growing market demand in Latin America, positioning the company for increased revenue in the region. (stocktitan.net)
Ashland's focus on research and development, particularly in sustainable and bio-based chemistries, is expected to strengthen its competitive position and unlock new revenue streams. (kappasignal.com)
Ashland reported a 14% decrease in sales for Q1 FY2025, largely impacted by ongoing portfolio optimization efforts, indicating potential challenges in revenue growth. (nasdaq.com)
The company experienced a significant net loss of $165 million in Q1 FY2025, compared to a profit of $26 million in the prior-year quarter, reflecting substantial financial distress. (nasdaq.com)
Ashland's specialty additives sales declined by 1% to $150 million due to increased competition in Asia, highlighting challenges in maintaining market share in key regions. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Ashland Financial Performance
Revenues and expenses
Ashland Earnings Performance
Company profitability
Ashland News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ashland stock?
Ashland (ASH) has a market cap of $2.3B as of June 30, 2025.
What is the P/E ratio for Ashland stock?
The price to earnings (P/E) ratio for Ashland (ASH) stock is 0 as of June 30, 2025.
Does Ashland stock pay dividends?
Yes, the Ashland (ASH) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is $1.63 and the yield is 3.27%. Ashland has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Ashland dividend payment date?
The next Ashland (ASH) dividend payment date is unconfirmed.
What is the beta indicator for Ashland?
Ashland (ASH) has a beta rating of 0.57. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.